Categories: CancerDNANews

Up to $1.6 Million in Funding Available for NSF Tissue Engineering Research Utilizing the ISS National Lab

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research

KENNEDY SPACE CENTER, Fla., Dec. 4, 2024 /PRNewswire/ — For the eighth consecutive year, the U.S. National Science Foundation (NSF) is funding a solicitation seeking projects that utilize the International Space Station (ISS) National Laboratory to advance tissue engineering and mechanobiology research. Through this solicitation, NSF will provide up to $1.6 million in total funding for multiple projects.

Microgravity affects organisms—from bacteria to humans, causing changes in gene expression and DNA regulation, altered cellular function and physiology, and 3D aggregation of cells. Research leveraging these effects can drive advances in the modeling of healthy and pathological tissues and organs, disease diagnosis and treatment, regenerative medicine, and many other areas within bioengineering and the biomedical sciences.

Fundamental science is a strategic focus area for the ISS National Lab, and knowledge gained from such studies could have profound impacts on future research and technology development that brings value to our nation and the scientific community. The Center for the Advancement of Science in Space™ (CASIS®), manager of the ISS National Lab, has established powerful multiyear partnerships with government agencies such as NSF to fund fundamental research on the orbiting laboratory. NSF supports transformative research to help drive the U.S. economy, enhance national security, and maintain America’s position as a global leader in innovation.

A project selected from a prior NSF-funded solicitation recently launched on SpaceX’s 31st Commercial Resupply Services (CRS) mission for NASA. The collaborative investigation from Oregon State University and Texas Tech University Health Sciences Center is using 3D-bioprinted cardiac organoids to study microgravity-induced atrophy on heart muscle cells. Results could lead to a better understanding of heart muscle atrophy, which occurs in several conditions, such as cancer, muscle disease, muscular dystrophy, diabetes, sepsis, and heart failure.

This solicitation follows a two-step proposal process. All interested investigators must first submit an ISS National Lab Feasibility Review Form for evaluation of the proposed concept’s operational feasibility. The deadline to submit a Feasibility Review Form is January 15, 2025. Only investigators whose concept passes the Feasibility Review step will be invited to submit a full proposal. The full proposal submission deadline is March 18, 2025.

For more information on this solicitation (NSF 25-513), including how to submit a Feasibility Review Form, visit the ISS National Lab solicitation webpage. To view the full solicitation, please see the NSF solicitation page.

To learn more about the benefits of conducting research leveraging the ISS National Lab, please visit our website.

Download a high-resolution image for this release: BioFabrication Facility on the ISS

About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space™ (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.

As a 501(c)(3) nonprofit organization, CASIS® accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.

Media Contact:            

Patrick O’Neill 

904-806-0035 

PONeill@ISSNationalLab.org

 

International Space Station (ISS) National Laboratory
Managed by the Center for the Advancement of Science in Space, Inc. (CASIS)

1005 Viera Blvd., Suite 101, Rockledge, FL 32955 • 321.253.5101 • www.ISSNationalLab.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/up-to-1-6-million-in-funding-available-for-nsf-tissue-engineering-research-utilizing-the-iss-national-lab-302322752.html

SOURCE International Space Station National Lab

Staff

Recent Posts

CoVet Expands Clinical Leadership with Launch of In-House Medical Department

Veterinary AI leader CoVet introduces a dedicated Medical Department to ensure clinical accuracy, real-world relevance,…

5 hours ago

New ASTHO Legal Map Illuminates State and Territorial Suicide Prevention Infrastructure

ARLINGTON, Va., July 24, 2025 /PRNewswire/ -- The Association of State and Territorial Health Officials…

5 hours ago

Loomis expands its Pharma business by acquiring Kipfer-Logistik

STOCKHOLM, Sweden, July 24, 2025 /PRNewswire/ -- Loomis AB has, through its subsidiary Loomis International…

5 hours ago

HealthArc and PatchRx Partner to Boost Medication Adherence in Pain Management

Integrated RTM solution to deliver real-time medication adherence insights for pain and mental health practices.…

5 hours ago

Loopback Analytics Welcomes Industry Leader Elizabeth Cherry as Vice President of Access Solutions

DALLAS, July 24, 2025 /PRNewswire/ -- Loopback Analytics is excited to welcome Elizabeth Cherry, PharmD,…

5 hours ago

123Invent Inventor Develops Modified Glasses to Assist with Reading (BRA-8028)

PITTSBURGH , July 24, 2025 /PRNewswire/ -- "I wanted to create reading glasses like to no…

5 hours ago